» Articles » PMID: 33225063

Experienced Facial Masking Indirectly Compromises Quality of Life Through Stigmatization of Women and Men with Parkinson's Disease

Overview
Journal Stigma Health
Specialty Public Health
Date 2020 Nov 23
PMID 33225063
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This study examined the relationship between self-reported facial masking and quality of life (QoL) in people with Parkinson's disease (PD), and tested experienced stigma as a mediator and gender as a moderator of this relationship. The strength of stigma as a mediator was compared against an alternative mediator, depression. Ninety people with PD (34 women) rated difficulty showing facial expression (masking), and completed the Stigma Scale for Chronic Illness, Geriatric Depression Scale (15-item), and Parkinson's Disease Questionnaire-39. A conditional process model tested the indirect effect of facial masking on QoL through stigma, separately for women and men. A parallel indirect model included both stigma and depression to compare their statistical and clinical significance as mediators. Gender-moderated mediation of stigma reduced the association between facial masking and QoL to non-significance, suggesting stigma explained the association between facial masking and QoL. While facial masking was more stigmatizing for women than for men, stigma mediated the facial masking-QoL association for both women and men. Stigma (controlling for depression) reached a statistically and clinically significant level of mediation, whereas depression (controlling for stigma) reached a statistically yet not clinically significant level of mediation. People with PD who experience more severe facial masking feel more stigmatized, especially women. Regardless of gender, an increase in stigma from facial masking increases the likelihood of compromised QoL that reaches both statistical and clinical levels of significance.

Citing Articles

Changes in Subjective Cognitive and Social Functioning in Parkinson's Disease from Before to During the COVID-19 Pandemic.

Mukadam N, Kinger S, Neargarder S, Salazar R, McDowell C, Wall J Healthcare (Basel). 2025; 13(1).

PMID: 39791677 PMC: 11719640. DOI: 10.3390/healthcare13010070.


Exploring the stigma experienced by people affected by Parkinson's disease: a systematic review.

Crooks S, Mitchell G, Wynne L, Carter G BMC Public Health. 2025; 25(1):25.

PMID: 39754132 PMC: 11697948. DOI: 10.1186/s12889-024-21236-8.


Validation Study of the Parkinson's Disease Stigma Questionnaire (PDStigmaQuest).

Stopic V, Jost S, Haupt J, Brandt G, van der Linden C, Petry-Schmelzer J J Parkinsons Dis. 2024; 14(7):1469-1480.

PMID: 39331110 PMC: 11492143. DOI: 10.3233/JPD-240224.


The Story behind the Mask: A Narrative Review on Hypomimia in Parkinson's Disease.

Bianchini E, Rinaldi D, Alborghetti M, Simonelli M, DAudino F, Onelli C Brain Sci. 2024; 14(1).

PMID: 38275529 PMC: 10814039. DOI: 10.3390/brainsci14010109.


Narrative medicine pinpoints loss of autonomy and stigma in Parkinson's disease.

Florijn B, Kloppenborg R, Kaptein A, Bloem B NPJ Parkinsons Dis. 2023; 9(1):152.

PMID: 37914740 PMC: 10620172. DOI: 10.1038/s41531-023-00593-y.


References
1.
Harris P, Taylor R, Thielke R, Payne J, Gonzalez N, Conde J . Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2008; 42(2):377-81. PMC: 2700030. DOI: 10.1016/j.jbi.2008.08.010. View

2.
Tickle-Degnen L, Zebrowitz L, Ma H . Culture, gender and health care stigma: Practitioners' response to facial masking experienced by people with Parkinson's disease. Soc Sci Med. 2011; 73(1):95-102. PMC: 3142938. DOI: 10.1016/j.socscimed.2011.05.008. View

3.
Peto V, Jenkinson C, Fitzpatrick R, Greenhall R . The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res. 1995; 4(3):241-8. DOI: 10.1007/BF02260863. View

4.
Ma H, Saint-Hilaire M, Thomas C, Tickle-Degnen L . Stigma as a key determinant of health-related quality of life in Parkinson's disease. Qual Life Res. 2016; 25(12):3037-3045. PMC: 5106304. DOI: 10.1007/s11136-016-1329-z. View

5.
Hemmesch A . The detrimental effects of atypical nonverbal behavior on older adults' first impressions of individuals with Parkinson's disease. Psychol Aging. 2014; 29(3):521-7. PMC: 4176769. DOI: 10.1037/a0036637. View